3-bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine, 95.0%, 100mg

21-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-4,7,10,13,16,19-hexaoxaheneicosanoic acid, 95%, 250mg

2-(Difluoromethyl)morpholine hydrochloride, 98%, 100mg

Umkehrfritte 1000 ml, Porosität 2, Kerne NS 29/32, Oliven Ø 8 mm, 1 Stück

Dicyclopentadiene (stabilised with BHT), 97.0%, 500g

3-Fluoro-4-methoxyphenylacetonitrile, 98.0%, 25g

3,6-Dibromo-2-fluorobenzaldehyde, 95+%, 25g

4-Fluorophthalonitrile>98.0%(GC)5g

[1-(6-Ethoxy-pyrimidin-4-yl)-piperidin-4-yl]-methanol, 95.0%, 250mg

cis-1,2-Cyclohexanedimethanol>97.0%(GC)5g

(S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 95%, 1g

Methyl 3-amino-6-bromopyrazine-2-carboxylate, 95.0%, 10g

6-methyl-1-phenyl-1,5-dihydro-4{H}-pyrazolo[3,4-{d}]pyrimidin-4-one, 95.0%, 500mg